chronic bronchitis COPD
Conditions
Interventions
16 Patients will receive 3 PESF treatments in 1 week and 16 patients will
receive 3 placebo treatments in 1 week.
Sponsors
Heerenveen Ziekenhuis, De Tjongerschans
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - 40-85 years old - Male and female - COPD patients, post-bronchodilator FEV1/FVC
Exclusion criteria
Exclusion criteria: - Known malignant condition with limited life expactancy - Carrier of electrical equipment (pacemaker, ICD etc.) - COPD exacerbation in the last 3 weeks - Participation in other research - Woman who are pregnant, breastfeeding or of childbearing age without effective contraception unless they meet the postmenopausal definition: 12 months of natural omenorrhea or 6 months of spontaneous ammenorrhea with serum FSH>40 mIU/mL or the use of one or more of the following acceptable methods of birth control: a) surgical sterilication, b) hormonal contraception, c) barrier methods: condom or occlusion cap with spermicide, d) constant abstention. - Manifest acute inflammation - Patients with manifest decompensatio cordis - Rehabilitation/reactivation programs within 2 months before or during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - oxygen saturation just before the first and immediately after the last PESF/placebo treatment - cap gas - CCQ-score (quality of life) - 6 minute walking test - squeenze force - phase angle (as a measurement for the muscle cell condition) - lung function | — |
Secondary
| Measure | Time frame |
|---|---|
| - oxygen saturation during and up to 24 hours after the PESF/placebo treatments | — |
Countries
Netherlands
Outcome results
None listed